|
Volumn 11, Issue 4, 2002, Pages 362-373
|
Proceedings of the consensus conference on the role of sentinel lymp node biopsy in carcinoma of the breast April 19-22, 2001, Philadelphia, PA, USA
a a a,z b c d e f g h i j k l m n o p q r more..
d
INSTITUT CURIE
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOKERATIN;
DISULFINE BLUE;
EOSIN;
HEMOLYSIN;
ISOSULFAN BLUE;
PARAFFIN;
RADIOPHARMACEUTICAL AGENT;
TECHNETIUM SULFUR COLLOID TC 99M;
AXILLARY LYMPH NODE;
BREAST CANCER;
BREAST DUCT;
CARCINOMA IN SITU;
CLINICAL PRACTICE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
EUROPE;
FROZEN SECTION;
HISTOPATHOLOGY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE DISSECTION;
MASTECTOMY;
MEDICAL DECISION MAKING;
METASTASIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SAFETY;
SENTINEL LYMPH NODE;
SENTINEL LYMPH NODE BIOPSY;
TREATMENT PLANNING;
UNITED STATES;
|
EID: 0036700721
PISSN: 09609776
EISSN: None
Source Type: Journal
DOI: 10.1054/brst.2002.0435 Document Type: Article |
Times cited : (12)
|
References (1)
|